Equatorial Guinea vs EUR: Hepatitis B surface antigen (HBsAg) prevalence (%)
Equatorial Guinea
2.0%
in 2024
EUR
0.1%
in 2024
Equatorial Guinea rank
12th
EUR rank
10th
Hepatitis B surface antigen (HBsAg) prevalence (%) over time
- Equatorial Guinea
- EUR
How they compare
Equatorial Guinea currently reports 2.0% against 0.1% in EUR, a difference of 1.9%.
That makes Equatorial Guinea's figure about 20.0 times EUR's.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
Equatorial Guinea ranks 12th and EUR ranks 10th of 194 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | EUR | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.3% | 0.1% | 2.2% | Equatorial Guinea |
| 2020s | 2.1% | 0.1% | 2.0% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Equatorial Guinea or EUR?
- Equatorial Guinea, at 2.0% against 0.1% in EUR as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Equatorial Guinea and EUR?
- 1.9%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and EUR?
- 10 years are reported by both, from 2015 to 2024.
- How do Equatorial Guinea and EUR rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Equatorial Guinea ranks 12th and EUR ranks 10th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.